ATE237806T1 - Neue reagenzien und methoden zur lyse von erythrozyten - Google Patents

Neue reagenzien und methoden zur lyse von erythrozyten

Info

Publication number: ATE237806T1
Authority: AT; Austria
Prior art keywords: erythrocytes; lysis; methods; new reagents; nitrogen containing
Prior art date: 1998-05-07

Application number

AT99430007T

Other languages

English (en)

Inventor

Agthoven Andre Van

David Jarrossay

Original Assignee

Immunotech Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-07

Filing date

1999-05-04

Publication date

2003-05-15

1999-05-04 Application filed by Immunotech Sa filed Critical Immunotech Sa

2003-05-15 Application granted granted Critical

2003-05-15 Publication of ATE237806T1 publication Critical patent/ATE237806T1/de

Links

239000003153 chemical reaction reagent Substances 0.000 title abstract 4
210000003743 erythrocyte Anatomy 0.000 title abstract 2
230000009089 cytolysis Effects 0.000 title 1
239000003146 anticoagulant agent Substances 0.000 abstract 2
229940127090 anticoagulant agent Drugs 0.000 abstract 2
230000002934 lysing effect Effects 0.000 abstract 2
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 abstract 1
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 abstract 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
-1 aliphatic aldehyde Chemical class 0.000 abstract 1
150000001450 anions Chemical class 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
239000008280 blood Substances 0.000 abstract 1
150000001768 cations Chemical class 0.000 abstract 1
239000000460 chlorine Substances 0.000 abstract 1
229910052801 chlorine Inorganic materials 0.000 abstract 1
210000000265 leukocyte Anatomy 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Cell Biology (AREA)
Hematology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
Ecology (AREA)
Food Science & Technology (AREA)
Tropical Medicine & Parasitology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Microbiology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT99430007T 1998-05-07 1999-05-04 Neue reagenzien und methoden zur lyse von erythrozyten ATE237806T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9806055A FR2778413B1 (fr)	1998-05-07	1998-05-07	Nouveaux reactifs et methode de lyse des erythrocytes

Publications (1)

Publication Number	Publication Date
ATE237806T1 true ATE237806T1 (de)	2003-05-15

Family

ID=9526319

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99430007T ATE237806T1 (de)	1998-05-07	1999-05-04	Neue reagenzien und methoden zur lyse von erythrozyten

Country Status (11)

Country	Link
US (1)	US6143567A (de)
EP (1)	EP0955543B1 (de)
JP (2)	JPH11352125A (de)
AT (1)	ATE237806T1 (de)
AU (1)	AU747910B2 (de)
DE (2)	DE955543T1 (de)
ES (1)	ES2141073T1 (de)
FR (1)	FR2778413B1 (de)
GR (1)	GR990300041T1 (de)
NO (1)	NO992206L (de)
NZ (1)	NZ335594A (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2813891B1 (fr) *	2000-09-14	2005-01-14	Immunotech Sa	Reactif multifonctionnel pour erythrocytes mettant en jeu des carbamates et applications
US7465584B2 (en) *	2005-01-24	2008-12-16	Sysmex Corporation	Method and reagent for classifying leukocytes in animal blood
DK3035798T3 (en) *	2013-08-20	2018-11-19	Univ Yeditepe	CELL CRYO-CONSERVATION MEDIUM ADDED TO DRILL
EP3151866B1 (de)	2014-06-09	2023-03-08	Voyager Therapeutics, Inc.	Chimäre kapside
RU2716991C2 (ru)	2014-11-05	2020-03-17	Вояджер Терапьютикс, Инк.	Полинуклеотиды aadc для лечения болезни паркинсона
KR20230145206A (ko)	2014-11-14	2023-10-17	보이저 테라퓨틱스, 인크.	조절성 폴리뉴클레오티드
WO2016077687A1 (en)	2014-11-14	2016-05-19	Voyager Therapeutics, Inc.	Compositions and methods of treating amyotrophic lateral sclerosis (als)
US11697825B2 (en)	2014-12-12	2023-07-11	Voyager Therapeutics, Inc.	Compositions and methods for the production of scAAV
WO2017075335A1 (en)	2015-10-28	2017-05-04	Voyager Therapeutics, Inc.	Regulatable expression using adeno-associated virus (aav)
US10215683B2 (en)	2015-11-02	2019-02-26	Chiranjit Deka	Light scatter based apparatus and methods for hematology analysis using only three detectors
EP3448874A4 (de)	2016-04-29	2020-04-22	Voyager Therapeutics, Inc.	Zusammensetzungen zur behandlung einer erkrankung
US11299751B2 (en)	2016-04-29	2022-04-12	Voyager Therapeutics, Inc.	Compositions for the treatment of disease
KR102427379B1 (ko)	2016-05-18	2022-08-02	보이저 테라퓨틱스, 인크.	헌팅톤 질환을 치료하기 위한 조성물 및 방법
KR20240056729A (ko)	2016-05-18	2024-04-30	보이저 테라퓨틱스, 인크.	조절성 폴리뉴클레오티드
WO2018044933A1 (en)	2016-08-30	2018-03-08	The Regents Of The University Of California	Methods for biomedical targeting and delivery and devices and systems for practicing the same
WO2018048586A1 (en) *	2016-09-06	2018-03-15	Chiranjit Deka	Improved reagent and method for identification and enumeration of basophils
JP2020518258A (ja)	2017-05-05	2020-06-25	ボイジャーセラピューティクスインコーポレイテッドＶｏｙａｇｅｒＴｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ．	筋萎縮性側索硬化症（ａｌｓ）治療組成物および方法
JP2020518259A (ja)	2017-05-05	2020-06-25	ボイジャーセラピューティクスインコーポレイテッドＶｏｙａｇｅｒＴｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ．	ハンチントン病治療組成物および方法
WO2018220835A1 (ja) *	2017-06-02	2018-12-06	日立化成株式会社	血液試料中の希少細胞を分離する方法及び該細胞の遺伝子を解析する方法
JOP20190269A1 (ar)	2017-06-15	2019-11-20	Voyager Therapeutics Inc	بولي نوكليوتيدات aadc لعلاج مرض باركنسون
CA3070087A1 (en)	2017-07-17	2019-01-24	Voyager Therapeutics, Inc.	Trajectory array guide system
EP3808849A1 (de)	2017-08-03	2021-04-21	Voyager Therapeutics, Inc.	Zusammensetzungen und verfahren zur aav-freisetzung
BR102018015288A2 (pt)	2017-08-08	2021-11-09	Euroimmun Medizinische Labordiagnostika Ag	Método para comprovar uma ativação de basófilos
EP3441763A1 (de)	2017-08-08	2019-02-13	Euroimmun Medizinische Labordiagnostika AG	Verfahren zum nachweis einer basophilenaktivierung
AU2018338728B2 (en)	2017-09-29	2025-01-02	Centre National De La Recherche Scientifique (Cnrs)	Rescue of central and peripheral neurological phenotype of Friedreich's Ataxia by intravenous delivery
EP3697908A1 (de)	2017-10-16	2020-08-26	Voyager Therapeutics, Inc.	Behandlung von amyotropher lateralsklerose (als)
TW202413649A (zh)	2017-10-16	2024-04-01	美商航海家醫療公司	肌萎縮性脊髓側索硬化症(als)之治療
EP3762500A1 (de)	2018-03-06	2021-01-13	Voyager Therapeutics, Inc.	Aus insektenzelle hergestellte teilweise selbstkomplementäre aav-genome
KR20210019996A (ko)	2018-05-15	2021-02-23	보이저 테라퓨틱스, 인크.	파킨슨병의 치료를 위한 조성물 및 방법
US20210207167A1 (en)	2018-05-16	2021-07-08	Voyager Therapeutics, Inc.	Aav serotypes for brain specific payload delivery
US20210214749A1 (en)	2018-05-16	2021-07-15	Voyager Therapeutics, Inc.	Directed evolution
US20210254103A1 (en)	2018-07-02	2021-08-19	Voyager Therapeutics, Inc.	Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
CN112770812A (zh)	2018-07-24	2021-05-07	沃雅戈治疗公司	产生基因治疗制剂的系统和方法
EP3856762A1 (de)	2018-09-28	2021-08-04	Voyager Therapeutics, Inc.	Frataxin-expressionskonstrukte mit gentechnisch veränderten promotoren und verfahren zu deren verwendung
WO2020072849A1 (en)	2018-10-04	2020-04-09	Voyager Therapeutics, Inc.	Methods for measuring the titer and potency of viral vector particles
SG11202107645RA (en)	2019-01-18	2021-08-30	Voyager Therapeutics Inc	Methods and systems for producing aav particles
EP3962536A1 (de)	2019-04-29	2022-03-09	Voyager Therapeutics, Inc.	Systeme und verfahren zur herstellung von baculovirusinfizierten insektenzellen (biics) in bioreaktoren
EP4010465A1 (de)	2019-08-09	2022-06-15	Voyager Therapeutics, Inc.	Zellkulturmedium zur verwendung bei der herstellung von gentherapieprodukten in bioreaktoren
EP4022070A1 (de)	2019-08-26	2022-07-06	Voyager Therapeutics, Inc.	Kontrollierte expression viraler proteine
CN111504887B (zh) *	2020-05-09	2023-05-09	苏州四正柏生物科技有限公司	一种溶血素及其制备方法
WO2022032153A1 (en)	2020-08-06	2022-02-10	Voyager Therapeutics, Inc.	Cell culture medium for use in producing gene therapy products in bioreactors
WO2022187548A1 (en)	2021-03-03	2022-09-09	Voyager Therapeutics, Inc.	Controlled expression of viral proteins
WO2022187473A2 (en)	2021-03-03	2022-09-09	Voyager Therapeutics, Inc.	Controlled expression of viral proteins
US20260085328A1 (en)	2022-09-08	2026-03-26	Voyager Therapeutics, Inc.	Controlled expression of viral proteins

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3884579A (en) *	1973-06-14	1975-05-20	Cambridge Chemical Products In	Method for counting blood platelets
US4284412A (en) *	1979-07-13	1981-08-18	Ortho Diagnostics, Inc.	Method and apparatus for automated identification and enumeration of specified blood cell subclasses
US4637986A (en) *	1983-08-22	1987-01-20	Ortho Diagnostic Systems, Inc.	Flow cytometry lysing reagent with leukoprotective agent for producing a 3-part WBC count
US4902613A (en) *	1984-05-14	1990-02-20	Becton, Dickinson And Company	Lysing agent for analysis of peripheral blood cells
US5188935A (en) *	1984-05-31	1993-02-23	Coulter Electronics, Inc.	Reagent system and method for identification, enumeration and examination of classes and subclasses of blood leukocytes
JP2836865B2 (ja) *	1989-10-23	1998-12-14	東亜医用電子株式会社	血液中の白血球およびヘモグロビンの測定用試薬
US5316951A (en) *	1991-06-07	1994-05-31	Carver Jr Edward L	Method for the improved determination of white blood cell subpopulations
JP3177863B2 (ja) *	1992-07-17	2001-06-18	東ソー株式会社	不安定型糖化ヘモグロビンの除去方法
EP0685994B1 (de) *	1993-02-25	2007-03-21	Abbott Laboratories	Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben
FR2705359B1 (fr) *	1993-05-19	1995-08-18	Immunotech Sa	Méthode de protection des cellules leucocytaires, composition protectrice, composition de sang protégée, et méthode d'analyse sanguine.
FR2705360B1 (fr) *	1993-05-19	1995-08-18	Immunotech Sa	Méthode et composition pour la lyse des érythrocytes, composition de sang, et méthode d'analyse leucocytaire.
JPH08189924A (ja) *	1994-03-07	1996-07-23	Sekisui Chem Co Ltd	安定型糖化ヘモグロビンの測定方法
JP3324050B2 (ja) *	1994-10-31	2002-09-17	日本光電工業株式会社	白血球分類用試薬および白血球分類方法
US5763280A (en) *	1997-01-21	1998-06-09	Coulter International Corp.	Cyanide-free lytic reagent composition and method for hemoglobin and cell analysis
JP3830613B2 (ja) *	1997-04-18	2006-10-04	シスメックス株式会社	血液中の白血球及びヘモグロビン濃度測定試薬
RU2216549C2 (ru) *	1997-11-07	2003-11-20	Дайити Фармасьютикал Ко., Лтд.	Пиперазин-циклодекстриновый комплекс и лекарственное средство, содержащее указанный комплекс

1998
- 1998-05-07 FR FR9806055A patent/FR2778413B1/fr not_active Expired - Fee Related
1999
- 1999-05-04 DE DE0955543T patent/DE955543T1/de active Pending
- 1999-05-04 DE DE69906859T patent/DE69906859T2/de not_active Expired - Lifetime
- 1999-05-04 GR GR990300041T patent/GR990300041T1/el unknown
- 1999-05-04 EP EP99430007A patent/EP0955543B1/de not_active Expired - Lifetime
- 1999-05-04 ES ES99430007T patent/ES2141073T1/es active Pending
- 1999-05-04 AT AT99430007T patent/ATE237806T1/de not_active IP Right Cessation
- 1999-05-05 NZ NZ335594A patent/NZ335594A/en unknown
- 1999-05-05 US US09/305,361 patent/US6143567A/en not_active Expired - Lifetime
- 1999-05-06 NO NO992206A patent/NO992206L/no not_active Application Discontinuation
- 1999-05-06 AU AU26984/99A patent/AU747910B2/en not_active Ceased
- 1999-05-07 JP JP11127385A patent/JPH11352125A/ja not_active Withdrawn
2008
- 2008-06-23 JP JP2008163866A patent/JP4446059B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU2698499A (en)	2000-04-13
EP0955543A1 (de)	1999-11-10
US6143567A (en)	2000-11-07
JPH11352125A (ja)	1999-12-24
JP2008224696A (ja)	2008-09-25
NO992206L (no)	1999-11-08
ES2141073T1 (es)	2000-03-16
JP4446059B2 (ja)	2010-04-07
GR990300041T1 (en)	2000-01-31
DE955543T1 (de)	2000-06-08
EP0955543B1 (de)	2003-04-16
FR2778413B1 (fr)	2000-08-04
DE69906859T2 (de)	2004-01-29
NO992206D0 (no)	1999-05-06
DE69906859D1 (de)	2003-05-22
NZ335594A (en)	2000-02-28
AU747910B2 (en)	2002-05-30
FR2778413A1 (fr)	1999-11-12

Legal Events

Date

Code

Title

Description

2003-11-15

UEP

Publication of translation of european patent specification

Ref document number: 0955543

Country of ref document: EP

2004-08-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE237806T1 (de)	2003-05-15	Neue reagenzien und methoden zur lyse von erythrozyten
ATE36457T1 (de)	1988-09-15	Verfahren zur inaktivierung von vermehrungsfaehigen krankheitserregern.
ATE83561T1 (de)	1993-01-15	Denaturierende reagenzien zur bestimmung von haemoglobinderivaten im blut.
DE69903236D1 (de)	2002-11-07	Reagenz zum Assay von Hämoglobin und zur Bestimmung der Leukozyten in einer Blutprobe
DE3751109D1 (de)	1995-04-06	Reagenzien zur Bestimmung von Peptidoglykan und beta-1,3-Glukan.
DE59510255D1 (de)	2002-08-08	Verfahren zum Nachweis von Störungen des Protein C/Protein S-Systems
ATE12318T1 (de)	1985-04-15	Verfahren und reagenz zur bestimmung von glykosiliertem haemoglobin.
ATE464562T1 (de)	2010-04-15	Lysereagens zur gleichzeitigen auszählung unterschiedlicher arten von blutzellen in einer blutprobe
DE69029291D1 (de)	1997-01-16	Verwendung von Lithiumsalzen zur Lysis von Erythrozyten und zur Denaturierung von Hämoglobin
ATE86669T1 (de)	1993-03-15	Zusammensetzung und verfahren zur stabilisierung von dinukleotiden.
DK56386A (da)	1986-08-06	Reagens til ved haemagglunitation at bestemme antistoffer mod bakterielle toksiner, fremgangsmaade til fremstilling af reagenset og dettes anvendelse
DE3765147D1 (de)	1990-10-31	Verfahren und reagenz zur bestimmung von gesamt-bilirubin.
ATE315226T1 (de)	2006-02-15	Verfahren zur herbeiführung zeitunabhängiger konsistenz in assays für mittlereteilchenvolumen
DE69903380D1 (de)	2002-11-14	Reagenz und Methode zur Permeabilisierung und zur Identifizierung von Erythrozyten
ES2136716T3 (es)	1999-12-01	Metodos y composicion para la lisis de los eritrocitos, composicion de sangre, y metodo de analisis leucocitario.
DE3685922D1 (de)	1992-08-13	Verfahren und reagenz zur beseitigung der stoerung der analyt-wiederfindung in plasmaproben.
DE60024923D1 (de)	2006-01-26	Verfahren zur Analyse der funktionellen Aktivierung von Leukocyten, Plättchen und anderen Zellen
GEP19970879B (en)	1997-10-07	Method for Determining Lead Contents in blood